HIGHLIGHTS OF PRESCRIBING INFORMATION - Novartis
When given with KISQALI, refer to the Full Prescribing Information for the recommended dose of the aromatase inhibitor being used. When given with KISQALI, the recommended dose of fulvestrant is 500 mg administered on Days 1, 15, 29, and once monthly thereafter. Please refer to the Full Prescribing Information of fulvestrant. ... Fetch This Document
LEUPROLIDE ACETATE INJECTION - Fertility By Design
LEUPROLIDE ACETATE INJECTION is a sterile, aqueous solution intended for subcutaneous injection. It is available in a 2.8 mL multiple-dose vial containing leuprolide acetate (5 mg/mL), sodium chloride, USP (6.3 mg/mL) for tonicity adjustment, benzyl alcohol, NF as a pres ervative (9 mg/mL), and water for injection, USP. ... Access Full Source
Leuprolide Acetate Injection
Lupron criteria Version 2 Last updated 10/04/09 ALASKA MEDICAID Leuprolide Acetate Injection LUPRON® and Leuprolide Acetate: 5mg/mL solution LUPRON DEPOT®: 3.75mg, 7.5mg, 11.25mg, 22.5mg, 30mg LUPRON DEPOT-PED®: 7.5mg, 11.25mg, 15mg Eligard®: 7.5mg, 22.5mg, 30mg, 45mg FOR DISPENSING BY THE PHARMACY ... View Doc
SPECIALTY GUIDELINE MANAGEMENT - Nhp.org
1. Prostate cancer: Leuprolide acetate is indicated in the palliative treatment of advanced prostate cancer. 2. Central precocious puberty (CPP): Leuprolide acetate is indicated in the treatment of children with central precocious puberty. B. Compendial Uses 1. Use as a stimulation test to confirm the diagnosis of CPP3-6 2. ... Fetch Full Source
HIGHLIGHTS OF PRESCRIBING INFORMATION Monitor Blood Glucose ...
Children. See the LUPRON DEPOT PED® package insert for the use of leuprolide acetate in children with central precocious puberty. • Geriatric: This label reflects clinical trials for LUPRON DEPOT in prostate cancer in which the majority of the subjects studied were at least 65 years of age. See 17 for PATIENT COUNSELING INFORMATION. ... Access This Document
Leuprolide Acetate (Lupron) - CHR
Leuprolide acetate (Lupron is a “GnRh agonist; Insert the needle through the top of the vial and inject the air. Do not See package insert for additional information regarding storage of the medication. F.Y.I. Lupron . ... View This Document
HIGHLIGHTS OF PRESCRIBING INFORMATION Pregnancy Or Suspected ...
FULL PRESCRIBING INFORMATION 1 INDICATIONS AND USAGE LUPANETA PACK (leuprolide acetate for depot suspension and norethindrone acetate tablets) is indicated for initial management of the painful symptoms of endometriosis and for ... Content Retrieval
FULL PRESCRIBING INFORMATION - HemOnc.org
FULL PRESCRIBING INFORMATION: CONTENTS* *Sections or subsections omitted from the full prescribing information are not listed. FULL PRESCRIBING INFORMATION 1 INDICATIONS AND USAGE FIRMAGON is a GnRH receptor antagonist indicated for treatment of patients with advanced prostate cancer. 2 DOSAGE AND ADMINISTRATION ... View This Document
SPECIALTY GUIDELINE MANAGEMENT - Caresource.com
High risk stratification when leuprolide acetate is used as initial androgen deprivation therapy (ADT). 3. Authorization of 12 months may be granted for treatment of regional or metastatic prostate cancer when leuprolide acetate is used as initial androgen deprivation therapy (ADT). 4. ... Read Here
HIGHLIGHTS OF PRESCRIBING INFORMATION Proteinuria: Monitor ...
Refer to everolimus prescribing information for recommended everolimus dosing information. 2.4 Recommended Dosage for Hepatocellular Carcinoma (HCC) The recommended dosage of LENVIMA is based on actual body weight: • 12 mg for patients greater than or equal to 60 kg or • 8 mg for patients less than 60 kg. ... Doc Viewer
DOSAGE AND ADMINISTRATION -------------------
2. DOSAGE AND ADMINISTRATION 2.1. Multiple Sclerosis (MS) Only prescribers registered in the MS TOUCH® Prescribing Program may prescribe TYSABRI for multiple sclerosis [see Warnings and Precautions (5.2)].The recommended dose of ... Access Doc
Excretion LUPRON DEPOT 7.5 Mg - HemOnc.org
200-621411 LUPRON DEPOT® 7.5 mg (leuprolide acetate for depot suspension) only DESCRIPTION Leuprolide acetate is a synthetic nonapeptide analog of naturally occurring ... Retrieve Document
HIGHLIGHTS OF PRESCRIBING INFORMATION Monitor Patients For ...
1 • Hypoadrenalism: Monitor patients for reduced serum cortisol levels and/or need for glucocorticoid dose increases in those with known hypoadrenalism. (5.8) • Hypothyroidism: Monitor thyroid function periodically as hypothyroidism may occur or worsen after initiation of ... Content Retrieval
Pharmacy Medical Necessity Guidelines: Leuprolide Acetate
2 Pharmacy Medical Necessity Guidelines: Leuprolide Acetate 1. Member has tried and failed therapy with, or there is a contraindication or intolerance to, hormonal therapy with one of the following: oral contraceptives, progestins or androgens OR 2. ... Read Content
Important New Update To The Prescribing Information For ...
Important New Update to the Prescribing Information for LUPRON DEPOT-PED® (leuprolide acetate for depot suspension) Injection, Powder, Lyophilized, For Suspension In May 2017, the LUPRON DEPOT-PED Prescribing Information (PI) was updated and key highlights are listed below. ... Fetch Full Source
Pharmacy Medical Necessity Guidelines: Leuprolide Acetate
Leuprolide Injection (leuprolide acetate) is indicated in the palliative treatment of advanced prostatic cancer. Lupron Depot (leuprolide acetate for depot suspension) 7.5 mg for 1 -month administration, 22.5 mg for ... Fetch Doc
LUPRON® INJECTION (leuprolide Acetate) Rx Only DESCRIPTION ...
(leuprolide acetate) Rx only DESCRIPTION Leuprolide acetate is a synthetic nonapeptide analog of naturally occurring gonadotropin releasing hormone (GnRH or LH-RH). The analog possesses greater potency than the natural hormone. The chemical ... Return Doc
Lupron 3.75 Mg Package Insert 03-5043-R12 Vs Revised Add-back ...
Lupron 3.75 mg Package Insert 03-5043-R12 Vs Revised Add-back (9-21-01) 2 Distribution The mean steady-state volume of distribution of leuprolide following intravenous bolus administration to healthy male volunteers was 27 L. ... Fetch Document
No comments:
Post a Comment